# EPINEPHRINE
> **ANDA220562** · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA PHARMS · Approved 2026-05-29
## Drug
- **FDA Application Number:** ANDA220562
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EPINEPHRINE
- **Generic name:** EPINEPHRINE
- **Active ingredients:** EPINEPHRINE
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** HIKMA PHARMS
- **Manufacturer:** Hikma Pharmaceuticals USA Inc.
- **First approval:** 2026-05-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220562)
---
*MORVS · CC0 1.0*